Vyndaqel Now Approved Page

Brand: Vyndaqel (tafamidis meglumine), Capsules
Parent Company: Pfizer
Drug Type: Prescription
Drug Category: Cardiovascular
Campaign: now-approved
Targeting: Patients
Patient Website: https://www.vyndaqel.com/
HCP Website: https://www.vyndaqelhcp.com/